• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剪接调控疗法在遗传性疾病治疗中的应用

Splicing modulation therapy in the treatment of genetic diseases.

作者信息

Arechavala-Gomeza Virginia, Khoo Bernard, Aartsma-Rus Annemieke

机构信息

Neuromuscular Disorders Group, BioCruces Health Research Institute, Barakaldo, Bizkaia, Spain.

Endocrinology, Division of Medicine, University College London, London, UK.

出版信息

Appl Clin Genet. 2014 Dec 4;7:245-52. doi: 10.2147/TACG.S71506. eCollection 2014.

DOI:10.2147/TACG.S71506
PMID:25506237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4259397/
Abstract

Antisense-mediated splicing modulation is a tool that can be exploited in several ways to provide a potential therapy for rare genetic diseases. This approach is currently being tested in clinical trials for Duchenne muscular dystrophy and spinal muscular atrophy. The present review outlines the versatility of the approach to correct cryptic splicing, modulate alternative splicing, restore the open reading frame, and induce protein knockdown, providing examples of each. Finally, we outline a possible path forward toward the clinical application of this approach for a wide variety of inherited rare diseases.

摘要

反义介导的剪接调控是一种可通过多种方式加以利用的工具,有望为罕见遗传病提供治疗方法。目前,这种方法正在杜氏肌营养不良症和脊髓性肌萎缩症的临床试验中进行测试。本综述概述了该方法在纠正隐蔽剪接、调控可变剪接、恢复开放阅读框以及诱导蛋白质敲低方面的多功能性,并分别给出了示例。最后,我们概述了将这种方法临床应用于多种遗传性罕见病的可能途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f406/4259397/4b8c60701112/tacg-7-245Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f406/4259397/e4a0b5f2f1a4/tacg-7-245Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f406/4259397/4b8c60701112/tacg-7-245Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f406/4259397/e4a0b5f2f1a4/tacg-7-245Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f406/4259397/4b8c60701112/tacg-7-245Fig2.jpg

相似文献

1
Splicing modulation therapy in the treatment of genetic diseases.剪接调控疗法在遗传性疾病治疗中的应用
Appl Clin Genet. 2014 Dec 4;7:245-52. doi: 10.2147/TACG.S71506. eCollection 2014.
2
Antisense-mediated modulation of splicing: therapeutic implications for Duchenne muscular dystrophy.反义寡核苷酸介导的剪接调控:杜氏肌营养不良症的治疗意义。
RNA Biol. 2010 Jul-Aug;7(4):453-61. doi: 10.4161/rna.7.4.12264. Epub 2010 Jul 1.
3
Designing Effective Antisense Oligonucleotides for Exon Skipping.设计用于外显子跳跃的有效反义寡核苷酸
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
4
RNA-targeted splice-correction therapy for neuromuscular disease.针对神经肌肉疾病的 RNA 靶向剪接校正治疗。
Brain. 2010 Apr;133(Pt 4):957-72. doi: 10.1093/brain/awq002. Epub 2010 Feb 11.
5
The therapeutic potential of antisense-mediated exon skipping.反义介导的外显子跳跃的治疗潜力。
Curr Opin Mol Ther. 2008 Apr;10(2):140-9.
6
Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases.反义介导的外显子跳跃:利用大自然的技巧治疗罕见遗传病。
Exp Cell Res. 2014 Jul 1;325(1):50-5. doi: 10.1016/j.yexcr.2014.01.026. Epub 2014 Jan 31.
7
Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications.寡核苷酸对 RNA 剪接的调控:作用机制及治疗意义。
Nucleic Acid Ther. 2022 Jun;32(3):123-138. doi: 10.1089/nat.2021.0067. Epub 2022 Feb 14.
8
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.基于反义寡核苷酸的神经肌肉疾病治疗
Molecules. 2017 Apr 5;22(4):563. doi: 10.3390/molecules22040563.
9
Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.反义介导的外显子跳跃:一种具有治疗和研究应用的通用工具。
RNA. 2007 Oct;13(10):1609-24. doi: 10.1261/rna.653607. Epub 2007 Aug 7.
10
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.反义寡核苷酸疗法用于儿童遗传性肺病的潜力。
Mol Cell Pediatr. 2018 Feb 6;5(1):3. doi: 10.1186/s40348-018-0081-6.

引用本文的文献

1
Alternative Splicing as a Modulator of the Interferon-Gamma Pathway.可变剪接作为干扰素-γ 通路的调节因子
Cancers (Basel). 2025 Feb 10;17(4):594. doi: 10.3390/cancers17040594.
2
Covalent targeting of splicing in T cells.T细胞中剪接的共价靶向
Cell Chem Biol. 2025 Jan 16;32(1):201-218.e17. doi: 10.1016/j.chembiol.2024.10.010. Epub 2024 Nov 25.
3
Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy.维托拉森在杜氏肌营养不良治疗中的作用演变

本文引用的文献

1
Dystrophin Analysis in Clinical Trials.临床试验中的肌营养不良蛋白分析
J Neuromuscul Dis. 2014;1(1):41-53.
2
Dystrophin quantification: Biological and translational research implications.肌营养不良蛋白定量:生物学及转化研究意义
Neurology. 2014 Nov 25;83(22):2062-9. doi: 10.1212/WNL.0000000000001025. Epub 2014 Oct 29.
3
Translational and regulatory challenges for exon skipping therapies.外显子跳跃疗法的转化和监管挑战。
Adv Ther. 2024 Apr;41(4):1338-1350. doi: 10.1007/s12325-024-02801-4. Epub 2024 Feb 20.
4
Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application.用于剪接转换应用的化学修饰核酸类似物的评估。
ACS Omega. 2023 Dec 11;8(51):48650-48661. doi: 10.1021/acsomega.3c07618. eCollection 2023 Dec 26.
5
The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations.长非编码 RNA、剪接因子、可变剪接及其调控的关联。
RNA Biol. 2024 Jan;21(1):1-20. doi: 10.1080/15476286.2023.2286099. Epub 2023 Nov 28.
6
Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.反义寡核苷酸临床前安全性评估的考虑因素。
Nucleic Acid Ther. 2023 Jan;33(1):1-16. doi: 10.1089/nat.2022.0061. Epub 2022 Dec 28.
7
Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example.剪接调控作为溶酶体贮积症的一种有前景的治疗策略:以黏多糖贮积症为例
Life (Basel). 2022 Apr 19;12(5):608. doi: 10.3390/life12050608.
8
Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy.评价杜氏肌营养不良症体外模型中的外显子跳跃和抗肌萎缩蛋白恢复。
Methods Mol Biol. 2022;2434:217-233. doi: 10.1007/978-1-0716-2010-6_14.
9
Antisense RNA Therapeutics: A Brief Overview.反义 RNA 治疗学:简要概述。
Methods Mol Biol. 2022;2434:33-49. doi: 10.1007/978-1-0716-2010-6_2.
10
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation.反义寡核苷酸介导的剪接转换:减轻癌症的潜在治疗方法。
Cancers (Basel). 2021 Nov 5;13(21):5555. doi: 10.3390/cancers13215555.
Hum Gene Ther. 2014 Oct;25(10):885-92. doi: 10.1089/hum.2014.086.
4
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates.中枢神经系统递送达运动神经元存活拼接寡核苷酸 2'-O-甲氧基乙基修饰物在小鼠和非人灵长类动物中的药理学研究。
J Pharmacol Exp Ther. 2014 Jul;350(1):46-55. doi: 10.1124/jpet.113.212407. Epub 2014 Apr 30.
5
Antisense-mediated exon skipping: networking to meet opportunities and to overcome challenges.反义介导的外显子跳跃:建立联系以把握机遇并克服挑战。
Nucleic Acid Ther. 2014 Feb;24(1):1-3. doi: 10.1089/nat.2014.1500.
6
The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome).2014年单基因神经肌肉疾病(核基因组)基因表版本
Neuromuscul Disord. 2013 Dec;23(12):1081-111. doi: 10.1016/j.nmd.2013.10.006.
7
Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials.脊髓性肌萎缩症的分子治疗策略:当前及未来的临床试验
Clin Ther. 2014 Jan 1;36(1):128-40. doi: 10.1016/j.clinthera.2013.11.006. Epub 2013 Dec 17.
8
The missing puzzle piece: splicing mutations.缺失的拼图碎片:剪接突变。
Int J Clin Exp Pathol. 2013 Nov 15;6(12):2675-82. eCollection 2013.
9
Eteplirsen for the treatment of Duchenne muscular dystrophy.依替膦酸酯治疗杜氏肌营养不良症。
Ann Neurol. 2013 Nov;74(5):637-47. doi: 10.1002/ana.23982. Epub 2013 Sep 10.
10
Splicing therapy for neuromuscular disease.神经肌肉疾病的剪接治疗。
Mol Cell Neurosci. 2013 Sep;56:169-85. doi: 10.1016/j.mcn.2013.04.005. Epub 2013 Apr 28.